Global Atrial Fibrillation Devices Market developed rapidly, with an average growth rate of 8.64%

Global Atrial Fibrillation Devices Market developed rapidly, with an average growth rate of 8.64%

In the last several years, global market of Atrial Fibrillation Devices developed rapidly, with an average growth rate of 8.64%. In 2017, global revenue of Atrial Fibrillation Devices is nearly 2.4 billion USD. The atrial fibrillation surgery market has immense growth potential from 2018 to 2025. The factors propelling growth in this market include increasing number of people suffering from atrial fibrillation and favorable regulations.

Click to view the full report TOC, figure and tables：
About 4.4% people out of diagnosed atrial fibrillation population are treated using ablation technology in the U.S., Europe, and Japan combined. The atrial fibrillation population treated with ablation is expected to grow with a double digit rate in these regions. The increasing prevalence of atrial fibrillation and advancement in the ablation technologies drive the use of ablation products in the treatment of atrial fibrillation.

This market is segmented, on the basis of surgical procedures, into catheter ablation and surgical ablation. Catheter ablation procedures hold the maximum share in this market and are expected to grow with the highest CAGR during forecast period of 2018 to 2025.

The geographical segmentation includes North America, Europe, Asia-Pacific, South America and Middle East & Africa. North America holds the largest share in this market. However, Asia-Pacific is expected to witness the highest growth rate owing to the presence of a large patient population, growing medical tourism, and high focus of global market players on emerging Asia-Pacific countries such as China and India.

The major players in global Atrial Fibrillation Devices market include
St. Jude Medical
Boston Scientific
Biosense Webster
Medtronic
Japan Lifeline
AtriCure
Biotronik
Philips
Synaptic Medical
Osypka AG
MicroPort Scientific
CardioFocus
Lepu Medical
APT Med
TZ Medical

Geographically, this report is segmented into several key Regions, with revenue, market share and growth rate of Atrial Fibrillation Devices in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
Asia-Pacific
South America
Middle East & Africa


On the basis of product, the Atrial Fibrillation Devices market is primarily split into
Catheter Ablation
Maze Surgery
On the basis on the end users/applications, this report covers
Hospitals
Clinics
Ambulatory Surgical Centers
Others

Request for more information@ sales@qyresearchglobal.com (use this link until we don’t have available new url for promotions)
https://www.qyresearch.com/index/detail/202277/global-atrial-fibrillation-devices-market

About Us: QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

Contact US

QY Research, INC.

Tina

Room 2901, VILI International Building, No.167 Linhe West Road Tianhe District ,

Guangzhou City Guangdong Province    

Tel: 0086-20-22093278(CN)

Email – sales@qyrsearchglobal.com or tinaning@qyrsearch.com

Web – www.qyresearch.com or http://www.qyresearchglobal.com/